EMFAT
RGLS

Emerald Mutual Fund Advisers Trust’s Regulus Therapeutics RGLS Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-515
Closed -$558K – 236
2014
Q1 		$558K Buy
+515
New +$571K 0.05% 183
2013
Q4 		– Sell
-1,584
Closed -$1.79M – 233
2013
Q3 		$1.79M Sell
1,584
-1,142
-42% -$1.35M 0.25% 109
2013
Q2 		$3.21M Buy
+2,726
New +$2.59M 0.54% 75

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's RGLS Position: Q2 2014 in Review

Emerald Mutual Fund Advisers Trust sold out of Regulus Therapeutics (RGLS) in Q2 2014, closing a stake of 515 shares — an estimated $558K sold.

Emerald Mutual Fund Advisers Trust first reported a position in RGLS in Q2 2013 and held it in 3 quarters. The position peaked at $3.21M in Q2 2013. 53 funds tracked by Wall St. Rank hold RGLS as of Q2 2014.

  • Emerald Mutual Fund Advisers Trust reported no remaining Regulus Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 515 Regulus Therapeutics shares in Q2 2014, an estimated $558K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Regulus Therapeutics in Q2 2013 and held it in 3 quarters.
  • Emerald Mutual Fund Advisers Trust's Regulus Therapeutics position peaked at $3.21M in Q2 2013.
  • 53 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2014.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2014, filed 17 Jul 2014.